A Case of Pediatric Nephrolithiasis Associated with Topiramate Treatment
Journal of the Korean Child Neurology Society
;
: 112-116, 2010.
Article
in English
| WPRIM
| ID: wpr-208699
ABSTRACT
Topiramate is an antiepileptic drug widely used to treat various seizures, mood disorders and migraine based on its various pharmacological mechanisms. Even though nephrolithiasis is listed as one of its side effects, there have been no cases reporting nephrolithiasis caused by use of topiramate on Korean pediatric patients. Since the use of topiramate is increasing in many patients, the possibility of nephrolithiasis after the treatment needs to be considered. Here, we report our experience in correcting neprholithiasis by simply discontinuing topiramate without administering any additional treatments.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Seizures
/
Mood Disorders
/
Nephrolithiasis
/
Fructose
/
Migraine Disorders
/
Anticonvulsants
Limits:
Humans
Language:
English
Journal:
Journal of the Korean Child Neurology Society
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS